Advertisement
UK markets closed

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • HANG SENG

    16,248.97
    -351.49 (-2.12%)
     

  • CRUDE OIL

    85.42
    +0.01 (+0.01%)
     

  • GOLD FUTURES

    2,406.40
    +23.40 (+0.98%)
     

  • DOW

    37,751.32
    +16.21 (+0.04%)
     

  • Bitcoin GBP

    50,458.98
    -487.74 (-0.96%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • NASDAQ Composite

    15,852.74
    -32.28 (-0.20%)
     

  • UK FTSE All Share

    4,260.41
    -78.49 (-1.81%)
     
Money:

How to avoid tax creep in retirement

The state pension went up 8.5% in April, but frozen thresholds mean pensioners will be paying more tax

Hikma Pharma to meet investors for potential dollar bond -leads

Reuters - UK Focus

DUBAI, March 25 (Reuters) - Hikma Pharmaceuticals Plc (LSE: HIK.L - news) , a drugs group founded in Jordan in 1978, has picked four banks to arrange a series of fixed income meetings starting Friday for a potential benchmark dollar bond, a document from lead arrangers showed.

The company has picked Citigroup (NYSE: C - news) , Barclays (LSE: BARC.L - news) , HSBC and National Bank (NYSE: NBHC - news) of Abu Dhabi to arrange investor meetings in Europe and the Middle East, the document stated.

Hikma, rated BB+ Standard (Other OTC: SNDH - news) and Poor's and Ba1 by Moody's, joined Britain's benchmark FTSE 100 equity index in March. Getting into the FTSE 100 can often fuel further demand for a company's shares, since funds that track the FTSE or invest in the index can then add that stock to their portfolio. (Reporting by Archana Narayanan; editing by Matt Smith)